Hypophosphatemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Diagnosis== | ==Diagnosis== | ||
*CNS | *CNS | ||
**Weakness | **[[Weakness]] | ||
**Circumoral and fingertip paresthesias | **Circumoral and fingertip paresthesias | ||
**Decreased DTRs | **Decreased DTRs | ||
**Decreased | **[[Decreased Mental Status]] | ||
*Cardiac | *Cardiac | ||
**Impaired myocardial function | **Impaired myocardial function | ||
| Line 18: | Line 18: | ||
#Severe | #Severe | ||
##KPhos 2.5-5 mg/kg IV over 6hr | ##KPhos 2.5-5 mg/kg IV over 6hr | ||
*If <2.4: | |||
**Neutra-Phos 2 packets PO Q6hr x 48hr OR sodium phosphate 30mmol IV | |||
*If <1: | |||
**IV Sodium Phosphate 45mmol should be used | |||
==Harbor UCLA Adult Treatment Guidelines== | ==Harbor UCLA Adult Treatment Guidelines== | ||
| Line 44: | Line 51: | ||
###Repeat IV administration if <1 mg/dl | ###Repeat IV administration if <1 mg/dl | ||
###Consider oral administration if >1mg and <2 mg/dl | ###Consider oral administration if >1mg and <2 mg/dl | ||
[[Category:FEN]] | |||
[[Category:FEN]] | [[Category:FEN]] | ||
Revision as of 07:34, 18 December 2013
Background
- 2.5-2.8 Mild
- 1.0-2.5 Mod
- <1.0 Severe
Diagnosis
- CNS
- Weakness
- Circumoral and fingertip paresthesias
- Decreased DTRs
- Decreased Mental Status
- Cardiac
- Impaired myocardial function
Treatment
- Mild-mod
- KPhos /neutra phos PO
- Severe
- KPhos 2.5-5 mg/kg IV over 6hr
- If <2.4:
- Neutra-Phos 2 packets PO Q6hr x 48hr OR sodium phosphate 30mmol IV
- If <1:
- IV Sodium Phosphate 45mmol should be used
Harbor UCLA Adult Treatment Guidelines
- Serum phosphate <2 mg/dl, but >1 mg/dl AND the patient IS able to take PO
- Minimize or eliminate all dextrose-containing IV solutions
- Aggressively treat acidosis
- 1 tab K-phos neutral 250mg Q hour x 5 doses
- Each tab contains phosphorus 8 mmol, Na 13 mEq, K1.1 mEq
- Recheck serum phosphate after last dose, and repeat dosing if continues to be <2 mg/dl
- Serum phosphate <2 mg/dl, but >1 mg/dl BUT the patient is NOT able to take PO
- Minimize or eliminate all dextrose-containing IV solutions
- Aggressively treat acidosis
- Give 15 mmol of IV potassium phosphate over 2.5 hours (contains 22 mEq K)
- Peripheral administration may cause burning at injection site
- Consider central venous administration, if available
- Repeat dosing regimen if serum phosphate remains <2 mg/dl
- Serum phosphate <1 mg/dl
- Minimize or eliminate all dextrose-containing IV solutions
- Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS
- Aggressively treat acidosis
- Give 45 mmol of IV potassium phosphate over 7 hours (contains 66 mEq of K)
- Peripheral administration may cause burning at injection site
- Consider central venous administration, if available
- If patient can tolerat PO, ALSO follow steps 1 above
- Recheck serum phosphate after infusion
- Repeat IV administration if <1 mg/dl
- Consider oral administration if >1mg and <2 mg/dl
- Minimize or eliminate all dextrose-containing IV solutions
